Zhen, Yuanli http://orcid.org/0000-0002-9383-9117
Liu, Kai
Shi, Lei
Shah, Simran
Xu, Qin http://orcid.org/0000-0002-5860-8225
Ellis, Haley
Balasooriya, Eranga R. http://orcid.org/0000-0002-5491-3089
Kreuzer, Johannes
Morris, Robert
Baldwin, Albert S.
Juric, Dejan http://orcid.org/0000-0003-2983-7704
Haas, Wilhelm
Bardeesy, Nabeel http://orcid.org/0000-0003-3867-0416
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P50CA127003)
United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs (CA210849)
V Foundation for Cancer Research (Translation Team Research Award)
Samuel Waxman Cancer Research Foundation (Team Award)
Brown | Warren Alpert Medical School, Brown University (Translational award)
Article History
Received: 14 August 2023
Accepted: 4 April 2024
First Online: 7 May 2024
Competing interests
: N.B. reports research grant support from Kinnate Biopharma, Tyra Biosciences, and Servier Laboratories. D.J. reports grants and personal fees from Novartis, Genentech, Syros, and Eisai, grants from Pfizer, Ribon Therapeutics, Infinity, InventisBio, Cyteir, and Arvinas, and personal fees from Relay Therapeutics, Vibliome, Mapkure, and PIC Therapeutics outside the submitted work. The remaining authors declare no competing interests.